GlucoTrack Statistics

Share Statistics

GlucoTrack has 15.5M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	15.5M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	10.15M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 3.07K, so 0% of the outstanding shares have been sold short.

Short Interest	3.07K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.93

Valuation Ratios

The PE ratio is 7.37 and the forward PE ratio is null. GlucoTrack's PEG ratio is -0.03.

PE Ratio	7.37
Forward PE	n/a
PS Ratio	0
Forward PS	n/a
PB Ratio	-12.81
P/FCF Ratio	-13.22
PEG Ratio	-0.03

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for GlucoTrack.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.52, with a Debt / Equity ratio of -0.02.

Current Ratio	4.52
Quick Ratio	4.52
Debt / Equity	-0.02
Debt / EBITDA	-0.01
Debt / FCF	-0.02
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$2.05M
Employee Count	11
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	22.6M
Effective Tax Rate	100%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is -1.66, so GlucoTrack's price volatility has been lower than the market average.

Beta	-1.66
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.49
Average Volume (20 Days)	5,947

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.55M
Net Income	22.6M
EBITDA	-21.98M
EBIT	-22.01M
Earnings Per Share (EPS)	60.76

Full Income Statement

Balance Sheet

The company has 5.62M in cash and 267K in debt, giving a net cash position of 5.35M.

Cash & Cash Equivalents	5.62M
Total Debt	267K
Net Cash	5.35M
Retained Earnings	-132.45M
Total Assets	6.26M
Working Capital	5.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.49M and capital expenditures -104K, giving a free cash flow of -12.59M.

Operating Cash Flow	-12.49M
Capital Expenditures	-104K
Free Cash Flow	-12.59M
FCF Per Share	-33.86

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IGAP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for IGAP.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Aug 13, 2021. It was a backward split with a ratio of 1:13.

Last Split Date	Aug 13, 2021
Split Type	backward
Split Ratio	1:13

Scores

Altman Z-Score	8.04
Piotroski F-Score	2

GlucoTrack Inc. (IGAP)